ArticleJournal of hematology & oncology2024

Redefining chimeric antigen receptor T-cell (CAR-T) regulation: China's responses to address secondary cancer risks of CAR-T therapy.

Ruirong Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.